Condition | Variable | Wald | OR | 95% CI | p-value | HS value | R square | AUC | 95% CI |
---|---|---|---|---|---|---|---|---|---|
Active BD | ESR* | 17.7 | 1.09 | 1.04–1.13 |  < 0.001 | 0.58 | 0.32 | 0.79 | 0.74–0.83 |
 | CRP | 0 | – | – | 0.99 |  |  | 0.71 | 0.66–0.76 |
Active vascular signs | ESR* | 18.2 | 1.03 | 1.01–1.05 |  < 0.001 | 0.78 | 0.37 | 0.85 | 0.79–0.92 |
 | CRP* | 18.4 | 1.98 | 1.45–2.72 |  < 0.001 |  |  | 0.86 | 0.8–0.91 |
Active ocular signs | ESR | 12.2 | 0.98 | 0.97–0.99 |  < 0.001 | 0.22 | 0.06 | 0.39 | 0.34–0.44 |
 | CRP | 0.8 | 0.91 | 0.76–1.1 | 0.35 |  |  | 0.41 | 0.36–0.46 |
Active oral signs | ESR | 30.5 | 1.03 | 1.02–1.04 |  < 0.001 |  < 0.001 | 0.23 | 0.74 | 0.7–0.79 |
 | CRP | 11.7 | 1.41 | 1.15–1.71 | 0.001 |  |  | 0.69 | 0.64–0.73 |
Active genital signs | ESR | 11.8 | 1.02 | 1.00–1.03 | 0.001 |  < 0.001 | 0.23 | 0.78 | 0.73–0.82 |
 | CRP | 25.0 | 1.67 | 1.36–2.04 |  < 0.001 |  |  | 0.78 | 0.73–0.83 |
Active joint signs | ESR | 30.5 | 1.03 | 1.02–1.05 |  < 0.001 | 0.001 | 0.25 | 0.84 | 0.8–0.87 |
 | CRP | 4.9 | 1.29 | 1.03–1.63 | 0.02 |  |  | 0.74 | 0.67–0.8 |
Active dermal signs | ESR | 14.3 | 1.02 | 1.00–1.03 |  < 0.001 |  < 0.001 | 0.17 | 0.74 | 0.7–0.78 |
 | CRP | 15.8 | 1.44 | 1.20–1.73 |  < 0.001 |  |  | 0.70 | 0.65–0.75 |
Positive pathergy test | ESR | 0.2 | 0.99 | 0.98–1.00 | 0.61 | 0.04 | 0.01 | 0.42 | 0.36–0.48 |
 | CRP | 1.4 | 0.86 | 0.69–1.09 | 0.22 |  |  | 0.43 | 0.37–0.49 |
Epididymitis** | ESR | 0.7 | 1.01 | 0.98–1.04 | 0.39 | 0.14 | 0.12 | 0.81 | 0.72–0.9 |
 | CRP | 2.8 | 1.77 | 0.91–3.42 | 0.08 |  |  | 0.83 | 0.74–0.91 |
Active GI signs** | ESR* | 3.9 | 1.07 | 1–1.15 | 0.04 | 1 | 0.5 | 0.97 | 0.94–1 |
 | CRP | 0.8 | 2.41 | 0.36–16.04 | 0.36 |  |  | 0.94 | 0.88–0.99 |
Active CNS signs** | ESR* | 6.0 | 1.03 | 1.00–1.06 | 0.01 | 0.77 | 0.14 | 0.77 | 0.59–0.95 |
 | CRP | 0.05 | 1.07 | 0.56–2.00 | 0.82 |  |  | 0.65 | 0.41–0.9 |